“…Insight into a potential common pathway has recently been highlighted by a series of studies that have implicated defects in nucleocytoplasmic transport as a shared consequence downstream of a variety of ALS-initiating mutations. These include the identification of ALS-causing mutations in the nuclear localization signals (NLSs) of FUS and hnRNPA1 (Dormann et al, 2010; Gal et al, 2011; Liu et al, 2016), evidence of impaired nucleocytoplasmic transport downstream of C9ORF72 -related ALS-FTD (Boeynaems et al, 2016; Freibaum et al, 2015; Jovičić et al, 2015; Shi et al, 2017; Zhang et al, 2015), and recognition that cytoplasmic protein aggregates of TDP-43, and cytoplasmic deposition of amyloids more generally, interfere with nucleocytoplasmic transport of protein and RNA (Woerner et al, 2016). In this review, we provide an overview of the current understanding of nucleocytoplasmic transport through the nuclear pore complex (NPC) in mammalian cells.…”